At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Multigam IV (5% vs. 10%) as Substitution Therapy in Patients With an Immunodeficiency Secondary to a Hematological Disorder to Evaluate Infusion Time, Tolerance and Satisfaction. A Monocentric Observational Belgian Study
In Brief
An observational study for Hematologic Diseases and Secondary Immune Deficiency. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this observational study is to compare the administration of standard of care Multigam IV 5% and standard of care Multigam IV 10% in order to observe changes in infusion time and infusion related reactions. Patient satisfaction, number of actions taken by the nursing staff during infusion and satisfaction of the nursing staff will also be evaluated.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHematologic Diseases, Secondary Immune Deficiency
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJun 2017
First PostedAug 2017
Primary CompletionOct 2017
Study CompletionDec 2017
TodayJul 2026
First PostedAug 16, 2017
Enrollment StartJun 30, 2017
Primary CompletionOct 31, 2017
Study CompletionDec 13, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.9 years ago